Table 1. Data details for the whole slide biopsy specimens used for the prostate cancer experiments.
| Nr. of slides per category | Training | Validation | Test | Total |
|---|---|---|---|---|
| Cancer | 48 (62.94 ± 29.23) | 31 (62.32 ± 27.88) | 45 (64.90 ± 25.22) | 124 (64.02 ± 26.78) |
| 2 + 3 | 0 | 1 | 0 | 1 |
| 3 + 2 | 0 | 2 | 0 | 2 |
| 3 + 3 | 11 | 9 | 14 | 34 |
| 3 + 4 | 23 | 9 | 12 | 44 |
| 3 + 5 | 0 | 0 | 1 | 1 |
| 4 + 3 | 7 | 6 | 10 | 23 |
| 4 + 4 | 5 | 1 | 3 | 9 |
| 4 + 5 | 2 | 2 | 3 | 7 |
| 5 + 3 | 0 | 1 | 0 | 1 |
| 5 + 4 | 0 | 0 | 2 | 2 |
| Normal | 52 | 19 | 30 | 101 |
| Total | 100 | 50 | 75 | 225 |
The first column indicates the categories and the first row indicates the different data sets. For the cancer category, slide distribution is also indicated according to Gleason Score. The numbers between brackets for the ‘Cancer’-row indicate the average volume percentage of cancer within the slides and the corresponding standard deviation.